Otsuka Holdings Co., Ltd. (OTSKY)

Market Cap	28.90B
Revenue (ttm)	14.82B
Net Income (ttm)	2.18B
Shares Out	n/a
EPS (ttm)	4.03
PE Ratio	13.24
Forward PE	n/a
Dividend	0.75 (2.80%)
Ex-Dividend Date	Dec 27, 2024

Volume	5,579
Average Volume	47,024
Open	26.97
Previous Close	26.35
Day's Range	26.58 - 26.97
52-Week Range	19.30 - 32.41
Beta	0.07
RSI	58.12
Earnings Date	Apr 30, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKY

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY